AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,356,166 | +21.5% | 3,012,182 | +12.1% | 0.00% | +33.3% |
| Q2 2023 | $125,403,458 | +53.2% | 2,685,874 | +25.6% | 0.00% | +50.0% |
| Q1 2023 | $81,834,046 | -29.4% | 2,138,893 | +1.1% | 0.00% | -33.3% |
| Q4 2022 | $115,988,091 | +95.7% | 2,116,571 | +21.6% | 0.00% | +50.0% |
| Q3 2022 | $59,267,000 | +378.4% | 1,740,593 | +32.8% | 0.00% | – |
| Q2 2022 | $12,389,000 | -28.8% | 1,311,014 | +6.9% | 0.00% | – |
| Q1 2022 | $17,410,000 | -29.7% | 1,226,911 | +4.8% | 0.00% | -100.0% |
| Q4 2021 | $24,755,000 | +2.5% | 1,170,419 | +8.3% | 0.00% | 0.0% |
| Q3 2021 | $24,151,000 | -8.1% | 1,080,585 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $26,290,000 | -8.1% | 1,059,636 | +7.5% | 0.00% | 0.0% |
| Q1 2021 | $28,595,000 | +25.4% | 985,720 | +11.6% | 0.00% | 0.0% |
| Q4 2020 | $22,796,000 | -13.3% | 883,563 | +3.5% | 0.00% | 0.0% |
| Q3 2020 | $26,288,000 | +95.3% | 853,773 | +58.1% | 0.00% | – |
| Q2 2020 | $13,459,000 | +107.0% | 540,076 | +76.1% | 0.00% | – |
| Q1 2020 | $6,503,000 | +3.0% | 306,719 | +7.8% | 0.00% | – |
| Q4 2019 | $6,316,000 | +50.5% | 284,596 | +54.2% | 0.00% | – |
| Q3 2019 | $4,198,000 | +631.4% | 184,525 | +515.1% | 0.00% | – |
| Q2 2019 | $574,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |